Comparison of Drug-Eluting Balloon and Standard Balloon Angioplasty for Infrapopliteal Arterial Diseases in Diabetic Patients

Objective: To consider the clinical outcomes and restenosis rates of drug-eluting balloons (DEBs) and percutaneous transluminal angioplasty (PTA) in diabetic patients with infrapopliteal (IP) arterial disease. Materials and Methods: This retrospective, single-center study included 51 patients (37 males; mean age: 63.43 ± 9.81 years) with diabetes mellitus having IP arterial disease, from October 2012 to September 2014. Twenty-two patients were treated with PTA, and 29 patients were treated with DEBs. After intervention, the patients were evaluated in the first week and every 3 months, clinically and radiologically. Univariate and multivariate analyses were used to evaluate the clinical outcomes of diabetic patients with IP arterial disease who were treated with either DEBs or PTA. Results: There were no statistically significant differences between the groups in terms of age and gender, risk factors, characteristics of lesions, or the diameters or length of the balloons (P >.05). Primary patency was higher in the DEB group than in the PTA group (97.8% vs 81.1%, P =.020) in the first 3 months. However, there was no statistically significant difference at 1-year follow-up (68.2% vs 48.5%, P =.131). At the 12-month follow-up, there was no difference in clinical improvement between the groups (P =.193). Conclusion: The findings of this study reveal that DEB is a safe alternative treatment method for IP arterial disease in diabetic patients. © The Author(s) 2016.

Yazar Oz I.I.
Serifoglu I.
Bilici M.
Altinbas N.K.
Oz E.B.
Akduman E.I.
Yayın Türü Article
Tek Biçim Adres https://hdl.handle.net/20.500.12628/4802
Tek Biçim Adres 10.1177/1538574416676019
Konu Başlıkları diabetes mellitus
drug-eluting balloon
infrapopliteal arterial disease
percutaneous transluminal angioplasty
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu
Dergi Adı Vascular and Endovascular Surgery
Dergi Cilt Bilgisi 50
Dergi Sayısı 8
Sayfalar 534 - 540
Yayın Yılı 2016
Eser Adı
[dc.title]
Comparison of Drug-Eluting Balloon and Standard Balloon Angioplasty for Infrapopliteal Arterial Diseases in Diabetic Patients
Yazar
[dc.contributor.author]
Oz I.I.
Yazar
[dc.contributor.author]
Serifoglu I.
Yazar
[dc.contributor.author]
Bilici M.
Yazar
[dc.contributor.author]
Altinbas N.K.
Yazar
[dc.contributor.author]
Oz E.B.
Yazar
[dc.contributor.author]
Akduman E.I.
Yayın Yılı
[dc.date.issued]
2016
Yayıncı
[dc.publisher]
SAGE Publications Inc.
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
Objective: To consider the clinical outcomes and restenosis rates of drug-eluting balloons (DEBs) and percutaneous transluminal angioplasty (PTA) in diabetic patients with infrapopliteal (IP) arterial disease. Materials and Methods: This retrospective, single-center study included 51 patients (37 males; mean age: 63.43 ± 9.81 years) with diabetes mellitus having IP arterial disease, from October 2012 to September 2014. Twenty-two patients were treated with PTA, and 29 patients were treated with DEBs. After intervention, the patients were evaluated in the first week and every 3 months, clinically and radiologically. Univariate and multivariate analyses were used to evaluate the clinical outcomes of diabetic patients with IP arterial disease who were treated with either DEBs or PTA. Results: There were no statistically significant differences between the groups in terms of age and gender, risk factors, characteristics of lesions, or the diameters or length of the balloons (P >.05). Primary patency was higher in the DEB group than in the PTA group (97.8% vs 81.1%, P =.020) in the first 3 months. However, there was no statistically significant difference at 1-year follow-up (68.2% vs 48.5%, P =.131). At the 12-month follow-up, there was no difference in clinical improvement between the groups (P =.193). Conclusion: The findings of this study reveal that DEB is a safe alternative treatment method for IP arterial disease in diabetic patients. © The Author(s) 2016.
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Konu Başlıkları
[dc.subject]
diabetes mellitus
Konu Başlıkları
[dc.subject]
drug-eluting balloon
Konu Başlıkları
[dc.subject]
infrapopliteal arterial disease
Konu Başlıkları
[dc.subject]
percutaneous transluminal angioplasty
Haklar
[dc.rights]
info:eu-repo/semantics/closedAccess
ISSN
[dc.identifier.issn]
1538-5744
İlk Sayfa Sayısı
[dc.identifier.startpage]
534
Son Sayfa Sayısı
[dc.identifier.endpage]
540
Dergi Adı
[dc.relation.journal]
Vascular and Endovascular Surgery
Dergi Sayısı
[dc.identifier.issue]
8
Dergi Cilt Bilgisi
[dc.identifier.volume]
50
Tek Biçim Adres
[dc.identifier.uri]
https://dx.doi.org/10.1177/1538574416676019
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/4802
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
15
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
09 Şubat 2024 05:40
Google Kontrol
Tıklayınız
patients arterial disease clinical diabetic treated follow-up difference months groups between outcomes significant statistically balloons length patency lesions characteristics Primary factors higher diameters Objective Author(s) method treatment alternative reveal findings Conclusion improvement 12-month However 1-year
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms